Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析

◆英語タイトル:Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15653
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:89
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Johnson & Johnson (JNJ) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Johnson & Johnson (J&J) researches and develops, manufactures and sells pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women’s health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, general surgery and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson Key Recent Developments

Mar 21,2019 Inhalable oxytocin a potential treatment for postpartum haemorrhage
Mar 06,2019 The American Association for Cancer Research and the Lung Cancer Initiative at Johnson & Johnson announce the inaugural AACR-Johnson & Johnson Lung Cancer Innovation Science grant recipients
Mar 06,2019 AACR, Johnson & Johnson fund Colorado search for lung conditions that allow growth of cancer
Mar 01,2019 Johnson & Johnson Consumer Highlights Innovation in Skin Science at 2019 American Academy of Dermatology Annual Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Johnson & Johnson – Key Facts
Johnson & Johnson – Key Employees
Johnson & Johnson – Key Employee Biographies
Johnson & Johnson – Major Products and Services
Johnson & Johnson – History
Johnson & Johnson – Company Statement
Johnson & Johnson – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Johnson & Johnson – Business Description
Business Segment: Consumer
Overview
Performance
Key Stats
Business Segment: Medical Devices
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific, Africa
Performance
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
Geographical Segment: Western Hemisphere excluding U.S.
Performance
R&D Overview
Johnson & Johnson – Corporate Strategy
Johnson & Johnson – SWOT Analysis
SWOT Analysis – Overview
Johnson & Johnson – Strengths
Johnson & Johnson – Weaknesses
Johnson & Johnson – Opportunities
Johnson & Johnson – Threats
Johnson & Johnson – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Johnson & Johnson, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 21, 2019: Inhalable oxytocin a potential treatment for postpartum haemorrhage
Mar 06, 2019: The American Association for Cancer Research and the Lung Cancer Initiative at Johnson & Johnson announce the inaugural AACR-Johnson & Johnson Lung Cancer Innovation Science grant recipients
Mar 06, 2019: AACR, Johnson & Johnson fund Colorado search for lung conditions that allow growth of cancer
Mar 01, 2019: Johnson & Johnson Consumer Highlights Innovation in Skin Science at 2019 American Academy of Dermatology Annual Meeting
Feb 27, 2019: Top pharma executives testify before US Senate over high prices
Feb 14, 2019: J&J to acquire surgical robotics firm Auris Health for $3.4bn
Feb 13, 2019: Dementia Consortium welcomes new partners to drug discovery collaboration
Feb 08, 2019: Johnson & Johnson to disclose drug prices in television ads
Feb 05, 2019: US Senate invites seven pharma majors to testify on price hikes
Jan 23, 2019: J&J agrees to settle hip implant claims in US for $120m
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Johnson & Johnson, Key Facts
Johnson & Johnson, Key Employees
Johnson & Johnson, Key Employee Biographies
Johnson & Johnson, Major Products and Services
Johnson & Johnson, History
Johnson & Johnson, Subsidiaries
Johnson & Johnson, Key Competitors
Johnson & Johnson, Ratios based on current share price
Johnson & Johnson, Annual Ratios
Johnson & Johnson, Annual Ratios (Cont...1)
Johnson & Johnson, Annual Ratios (Cont...2)
Johnson & Johnson, Interim Ratios
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Johnson & Johnson, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Johnson & Johnson, Performance Chart (2014 - 2018)
Johnson & Johnson, Ratio Charts
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Panmure Gordon & Co Limited (PMR):企業の財務・戦略的SWOT分析
    Panmure Gordon & Co Limited (PMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • J D Wetherspoon plc:企業の戦略・SWOT・財務分析
    J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report Summary J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sabah Electricity Sdn Bhd:企業の戦略的SWOT分析
    Sabah Electricity Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sistema JSFC:企業の戦略・SWOT・財務情報
    Sistema JSFC - Strategy, SWOT and Corporate Finance Report Summary Sistema JSFC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • PrairieSky Royalty Ltd (PSK):石油・ガス:M&Aディール及び事業提携情報
    Summary PrairieSky Royalty Ltd (PrairieSky Royalty) is an oil and gas company. The company carries out acquisition of fee simple lands from Encana Corporation and concurrent initial public offering. It also acquires and manages royalty lands, to generate free cash flow through indirect third-party o …
  • Partners HealthCare System Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Partners HealthCare System Inc (PHS) is a non-profit integrated healthcare organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other healthcare entities …
  • Alnylam Pharmaceuticals Inc (ALNY):医療機器:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ratnamani Metals and Tubes Ltd:企業の戦略・SWOT・財務情報
    Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report Summary Ratnamani Metals and Tubes Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MAB Discovery GmbH-製薬・医療分野:企業M&A・提携分析
    Summary MAB Discovery GmbH (MAB Discovery) is a drug discovery and development company that offers novel antibody therapeutics. The company produces monoclonal antibodies derived from rabbits and rats. It relies on natural immune response and state of the art B cell cloning techniques for the produc …
  • OTK GROUP, a.s.:企業の戦略・SWOT・財務分析
    OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report Summary OTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • China Foods Limited:企業の戦略・SWOT・財務情報
    China Foods Limited - Strategy, SWOT and Corporate Finance Report Summary China Foods Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ferring International Center SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ferring International Center SA (Ferring) researches, develops and markets pharmaceutical products. The company offers pharmaceutical products in the fields of reproductive health, gastroenterology, endocrinology, urology and orthopedics. Some of the marketed products include Rekovelle (foll …
  • The Tokyo Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    The Tokyo Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • The Bank of East Asia, Limited:企業の戦略・SWOT・財務情報
    The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report Summary The Bank of East Asia, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bovie Medical Corp (BVX):医療機器:M&Aディール及び事業提携情報
    Summary Bovie Medical Corp (Bovie Medical) is a manufacturer of medical devices and supplies. The company’s product portfolio includes jplasma, electrosurgery generators and accessories, veterinary products, acudop ii dopplers, clearspec speculum, colposcopes, cryosurgery, dermascout dermatoscope, m …
  • Cathedral Energy Services Ltd (CET):企業の財務・戦略的SWOT分析
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, production testing services, measurement while drilling services a …
  • William Hill PLC:企業の戦略・SWOT・財務情報
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PT Pembangkitan Jawa-Bali-エネルギー分野:企業M&A・提携分析
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆